Trials / No Longer Available
No Longer AvailableNCT02148146
Use of Omega 3 Oil Emulsion for Parenteral Nutrition Associated Cholestasis
Clinical Trial of Omegaven™ Therapy for Parenteral Nutrition Associated Cholestasis
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- University of California, San Diego · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a clinical study designed to evaluate the safety and benefit of a fish oil based fat emulsion in the treatment of liver disease associated with prolonged use of intravenous nutrition.
Detailed description
Specific Aims of Study 1. To determine the safety profile of an intravenous omega-3 fat emulsion (Omegaven™) 2. To determine if established PN associated liver disease can be reversed or its progression halted by using a parenteral fat emulsion prepared from fish oil as measured by normalization of serum levels of hepatic enzymes and bilirubin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Omegaven | Fish oil emulsion given 1g/kg/day as infusion |
Timeline
- First posted
- 2014-05-28
- Last updated
- 2021-01-12
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02148146. Inclusion in this directory is not an endorsement.